After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Biolife Solutions Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Instruments & Supplies industry. The current market capitalization of Biolife Solutions Inc is $1.33B. A total of 1.08 million shares were traded on the day, compared to an average of 383.63K shares.
In the most recent transaction, Mathew Aby J. sold 13,196 shares of BLFS for 27.16 per share on Dec 17 ’24. After the transaction, the EVP & Chief Scientific Officer now owns 263,119 company shares. In a previous transaction on Dec 16 ’24, Mathew Aby J. sold 7,604 shares at 27.33 per share. BLFS shares that EVP & Chief Scientific Officer owns now total 276,315.
Among the insiders who sold shares, Wichterman Troy disposed of 581 shares on Nov 26 ’24 at a per-share price of $27.20. This resulted in the Chief Financial Officer holding 122,766 shares of BLFS after the transaction. In another insider transaction, Mathew Aby J. sold 523 shares at $27.20 per share on Nov 26 ’24. Company shares held by the EVP & Chief Scientific Officer now total 283,919.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BLFS has a high of $28.88 and a low of $14.50.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BLFS’s latest balance sheet shows that the firm has $69.86M in Cash & Short Term Investments as of fiscal 2021. There were $26.88M in debt and $42.70M in liabilities at the time. Its Book Value Per Share was $7.04, while its Total Shareholder’s Equity was $478.05M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLFS is Buy with a score of 5.00.
